Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Non-Current Liabilities (2020 - 2025)

Maravai Lifesciences Holdings has reported Total Non-Current Liabilities over the past 6 years, most recently at $361.4 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $361.4 million for Q4 2025, down 4.54% from a year ago — trailing twelve months through Dec 2025 was $361.4 million (down 4.54% YoY), and the annual figure for FY2025 was $361.4 million, down 4.54%.
  • Total Non-Current Liabilities for Q4 2025 was $361.4 million at Maravai Lifesciences Holdings, down from $379.4 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for MRVI hit a ceiling of $1.4 billion in Q3 2021 and a floor of $361.4 million in Q4 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $1.2 billion (2021), compared with a mean of $947.0 million.
  • Biggest five-year swings in Total Non-Current Liabilities: grew 23.27% in 2021 and later tumbled 54.87% in 2024.
  • Maravai Lifesciences Holdings' Total Non-Current Liabilities stood at $1.4 billion in 2021, then dropped by 0.43% to $1.4 billion in 2022, then crashed by 53.33% to $638.1 million in 2023, then tumbled by 40.67% to $378.6 million in 2024, then decreased by 4.54% to $361.4 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $361.4 million (Q4 2025), $379.4 million (Q3 2025), and $390.8 million (Q2 2025) per Business Quant data.